Endo Int’l Plc (NASDAQ:ENDP) shares traded -3.59% down during most recent session to reach at the closing price of $8.33. The stock exchanged hands 3.85 Million shares versus average trading capacity of 6.3 Million shares, yielding a market cap of $1.86 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $12.56 within the next 52-weeks. The mean target projections are based on 16 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Endo Int’l Plc (NASDAQ:ENDP) high price target of $19 and with a conservative view have low price target of $8.

Morgan Stanley “Maintained” Endo Int’l Plc (NASDAQ:ENDP) in a research note issued to investors on 8/10/17 to Equal-Weight with price target of $8.

Additionally on 8/09/17 Deutsche Bank “Maintained” Endo Int’l Plc (NASDAQ:ENDP) to Buy setting price target at $13 and on 6/16/17 Cantor Fitzgerald “Initiates Coverage On” the stock to Neutral at $12. Furthermore on 6/09/17 Stifel Nicolaus “Downgrades” the stock to Hold at $0.

In terms of Buy, Sell or Hold recommendations, Endo Int’l Plc (NASDAQ:ENDP) has analysts’ mean recommendation of 2.7. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Endo Int’l Plc (NASDAQ:ENDP)’s minimum EPS for the current quarter is at $0.55 and can go high up to $0.71. The consensus mean EPS for the current quarter is at $0.66 derived from a total of 17 estimates from the analysts who have weighed in on projected earnings. However the company reported $1.01 earnings per share for the same quarter during last year.

Previously Endo Int’l Plc (NASDAQ:ENDP) reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.2. The company posted an earnings surprise of 27.4%.

While considering growth estimates of the company, it has next quarter growth estimates of -59.9% whereas during current quarter it has -34.7% estimations over growth, comparing to the estimations of -25.8% during current year and -12.8% for next year. Past 5 years growth of Endo Int’l Plc (NASDAQ:ENDP) observed at -2.88%, looking forward for the next 5 years it has a strong prediction of -17.65% over growth.

Endo Int’l Plc (NASDAQ:ENDP)’s revenue estimates for the current quarter are $781.61 Million according to 14 number of analysts, for the current quarter the company has high revenue estimates of $817 Million in contradiction of low revenue estimates of $742.1 Million. For the current year the company’s revenue estimates are $3.46 Billion compared to low analyst estimates of $3.4 Billion and high estimates of $3.52 Billion according to 19 number of analysts.

Currently Endo Int’l Plc (NASDAQ:ENDP)’s shares owned by insiders are 0.4%, whereas shares owned by institutional owners are 95.8%. However the six-month change in the insider ownership was recorded 3.84%, as well as three-month change in the institutional ownership was recorded -2.07%.

Endo Int’l Plc (NASDAQ:ENDP)’s trailing twelve month revenues are $4.04 Billion, whereas its price to sales ratio for the same period is 0.46. Its book value per share for the most recent quarter is $3.63 while its price to book ratio for the same period is 2.29, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.